We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.
CSII

Delisted

CSII was delisted on the 27th of April, 2023.

Back to rankings

150 hedge funds and large institutions have $767M invested in Cardiovascular Systems, Inc. in 2023 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 36 increasing their positions, 56 reducing their positions, and 48 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more capital invested

Capital invested by funds: $490M → $767M (+$277M)

7% less funds holding

Funds holding: 162 → 150 (-12)

21% less first-time investments, than exits

New positions opened: 38 | Existing positions closed: 48

36% less repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 56

53% less call options, than puts

Call options by funds: $2.63M | Put options by funds: $5.66M

Holders
150
Holders Change
-12
Holders Change %
-7.41%
% of All Funds
2.39%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
38
Increased
36
Reduced
56
Closed
48
Calls
$2.63M
Puts
$5.66M
Net Calls
-$3.02M
Net Calls Change
-$2.87M

Top Buyers

Rank Fund Capital Flow
1
PCM
Pentwater Capital Management
Florida
+$30.1M
2
WIC
Water Island Capital
New York
+$27.6M
3
AAM
Alpine Associates Management
Florida
+$25M
4
GF
Gabelli Funds
New York
+$14.7M
5
AA
AQR Arbitrage
Connecticut
+$9.52M

Top Sellers

Rank Fund Capital Flow
1
CCM
Camber Capital Management
Massachusetts
-$17.7M
2
Federated Hermes
Federated Hermes
Pennsylvania
-$16.9M
3
Citadel Advisors
Citadel Advisors
Florida
-$12.8M
4
BlackRock
BlackRock
New York
-$12.4M
5
ACH
ArrowMark Colorado Holdings
Colorado
-$10.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$6.25M +$36.1K +2,091 +0.7%
E
27
Ergoteles
New York
$6.02M +$5.23M +303,083 New
UBS Group
28
UBS Group
Switzerland
$5.91M +$4.98M +288,400 +3,207%
Ameriprise
29
Ameriprise
Minnesota
$5.79M +$1.2M +69,676 +31%
GCIA
30
Gabelli & Co Investment Advisers
New York
$5.78M +$5.02M +290,850 New
DCM
31
DAFNA Capital Management
California
$5.7M – – –
Principal Financial Group
32
Principal Financial Group
Iowa
$5.16M -$67.6K -3,916 -1%
CCM
33
Chicago Capital Management
Illinois
$5.11M +$4.44M +257,190 New
D.E. Shaw & Co
34
D.E. Shaw & Co
New York
$4.1M -$3.16M -183,214 -47%
EFI
35
EHP Funds Inc
Canada
$3.97M +$3.45M +200,000 New
GLAM
36
Gardner Lewis Asset Management
Pennsylvania
$3.88M +$3.37M +195,309 New
Invesco
37
Invesco
Georgia
$3.73M -$643K -37,243 -17%
GKIM
38
GW&K Investment Management
Massachusetts
$3.65M +$6.18K +358 +0.2%
CS
39
Credit Suisse
Switzerland
$3.56M +$2.32M +134,098 +296%
TCM
40
Tekla Capital Management
Massachusetts
$3.47M – – –
SSA
41
Schonfeld Strategic Advisors
New York
$3.4M +$2.96M +171,170 New
Susquehanna International Group
42
Susquehanna International Group
Pennsylvania
$3.32M +$2.88M +166,986 New
VI
43
Versor Investments
New York
$2.88M +$2.5M +144,954 New
MF
44
Magnetar Financial
Illinois
$2.87M +$2.5M +144,661 New
PCM
45
Prelude Capital Management
New York
$2.75M +$2.39M +138,403 New
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$2.62M +$121K +6,995 +6%
Legal & General Group
47
Legal & General Group
United Kingdom
$1.99M -$11K -638 -0.6%
SCM
48
Soleus Capital Management
Connecticut
$1.89M +$1.65M +95,346 New
Swiss National Bank
49
Swiss National Bank
Switzerland
$1.8M -$147K -8,500 -9%
KC
50
Kellner Capital
New York
$1.59M +$1.38M +79,900 New
1
2
3 4 5

CSII Hedge Fund Activity: Q1 2023 in Review

150 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q1 2023, worth a combined $767M — up 57% from $490M a quarter earlier.

Sellers outnumbered buyers: 48 funds closed out of CSII and 38 opened new positions — a net loss of 10 holders — while 56 trimmed existing stakes and 36 added.

The largest buyer was Pentwater Capital Management, opening a new position worth an estimated $30.1M. The largest seller was Camber Capital Management, exiting entirely with an estimated $17.7M sold.

  • 150 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q1 2023, down from 162 in Q4 2022.
  • Funds reported $767M of Cardiovascular Systems, Inc. stock for Q1 2023, up 57% quarter-over-quarter.
  • 38 funds opened new Cardiovascular Systems, Inc. positions in Q1 2023 and 48 closed out, a net change of -10 holders.
  • The largest Cardiovascular Systems, Inc. buyer in Q1 2023 was Pentwater Capital Management, an estimated $30.1M added.
  • The largest Cardiovascular Systems, Inc. seller in Q1 2023 was Camber Capital Management, an estimated $17.7M sold.

Based on aggregated 13F filings for Q1 2023.